{"pmid":32354685,"pmcid":"PMC7160056","title":"Why Choose Cyclosporin A as First-line Therapy in COVID-19 Pneumonia.","text":["Why Choose Cyclosporin A as First-line Therapy in COVID-19 Pneumonia.","Reumatol Clin","Sanchez-Pernaute, Olga","Romero-Bueno, Fredeswinda I","Selva-O'Callaghan, Albert","32354685"],"journal":"Reumatol Clin","authors":["Sanchez-Pernaute, Olga","Romero-Bueno, Fredeswinda I","Selva-O'Callaghan, Albert"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32354685","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.reuma.2020.03.001","locations":["Pneumonia"],"e_drugs":["Cyclosporine"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138495179030529,"score":9.490897,"similar":[{"pmid":32376422,"pmcid":"PMC7196541","title":"Cyclosporine therapy during the COVID-19 pandemic is not a reason for concern.","text":["Cyclosporine therapy during the COVID-19 pandemic is not a reason for concern.","J Am Acad Dermatol","Rudnicka, Lidia","Goldust, Mohamad","Glowacka, Paulina","Sikora, Mariusz","Sar-Pomian, Marta","Rakowska, Adriana","Samochocki, Zbigniew","Olszewska, Malgorzata","32376422"],"journal":"J Am Acad Dermatol","authors":["Rudnicka, Lidia","Goldust, Mohamad","Glowacka, Paulina","Sikora, Mariusz","Sar-Pomian, Marta","Rakowska, Adriana","Samochocki, Zbigniew","Olszewska, Malgorzata"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32376422","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.jaad.2020.04.153","keywords":["covid-19","autoimmune disease","cyclosporine","dermatology","immunosuppressants","virus"],"e_drugs":["Cyclosporine"],"topics":["Treatment"],"weight":1,"_version_":1666596532358479872,"score":43.348392}]}